Pricing and Access—From IRA to Innovation: 2024 Trends

Estimated read time 1 min read

A look at how legislation—and the wider quest for more transparency on drug costs and reimbursement—may impact manufacturer product launch and pricing strategies in the years ahead.

You May Also Like

More From Author

+ There are no comments

Add yours